24,25-epoxycholesterol has been researched along with mevalonolactone in 1 studies
| Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (mevalonolactone) | Trials (mevalonolactone) | Recent Studies (post-2010) (mevalonolactone) |
|---|---|---|---|---|---|
| 65 | 0 | 18 | 185 | 1 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Rudney, H; Sexton, RC | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and mevalonolactone
| Article | Year |
|---|---|
Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestina
Topics: Animals; Cholesterol; Cholesterol Esters; Cytochrome P-450 Enzyme System; Epithelium; Hydroxymethylglutaryl CoA Reductases; Intestines; Ketoconazole; Lipoproteins, LDL; Mevalonic Acid; Models, Chemical; Oleic Acid; Oleic Acids; Rats; Sterol O-Acyltransferase; Sterols | 1986 |